Effect of taurine administration on symptoms, severity, or clinical outcome of dilated cardiomyopathy and heart failure in humans: a systematic review [version 3; peer review: 2 approved]
Background: Taurine, 2-aminoethanesulfonic acid, is an amino acid found in animal products. Taurine is produced for human consumption as a supplement and ingredient in beverages. Supplementation is a safe, inexpensive, and effective treatment for dilated cardiomyopathy (DCM) in domestic mammals, how...
Main Authors: | James S. Ware, Melpomeni Kasapi, Kathryn A. McGurk |
---|---|
Format: | Article |
Language: | English |
Published: |
Wellcome
2022-07-01
|
Series: | Wellcome Open Research |
Subjects: | |
Online Access: | https://wellcomeopenresearch.org/articles/7-9/v3 |
Similar Items
-
Effect of taurine administration on symptoms, severity, or clinical outcome of dilated cardiomyopathy and heart failure in humans: a systematic review [version 2; peer review: 2 approved]
by: James S. Ware, et al.
Published: (2022-02-01) -
Multimodal characterization of dilated cardiomyopathy: Geno‐ And Phenotyping of PrImary Cardiomyopathy (GrAPHIC)
by: Laura Keil, et al.
Published: (2024-02-01) -
Comprehensive review on gene mutations contributing to dilated cardiomyopathy
by: Shipeng Wang, et al.
Published: (2023-12-01) -
Dilated cardiomyopathy associated with NRAP gene: a case series
by: Abdellh A. Names, et al.
Published: (2023-06-01) -
Preliminary Data on Echocardiographic Evaluation and Serum Taurine Concentration in Healthy Dogs of Two Breeds (10 Golden Retrievers and 12 German Shorthaired Pointers) with Different Predispositions to Nutritional Dilated Cardiomyopathy: A Pilot Study
by: Mara Bagardi, et al.
Published: (2022-10-01)